Neurothrombectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares); By End-Use (Hospitals, Emergency Clinics, Ambulatory Surgical Centers), By Region; Segment Forecast, 2021 - 2028

Published Date: Feb 2021
Pages: 118
格式：PDF.
报告ID：PM1798
基数：2020
历史数据：2016 - 2019年

报告摘要

The global neurothrombectomy devices market was valued at USD 635.4 million in 2020 and is expected to grow at a CAGR of 6.7% during the forecast period. Increasing incidence of acute ischemic heart strokes, faulty lifestyles, coupled with increasing number of smokers and drinkers, and ever rising old age population are the key factors responsible for the neurothrombectomy devices market growth. Such devices used to retrieve blood clots in the cerebral neuro-vascular blood vessels.

了解有关此报告的更多信息：request for sample pages

These procedures improve patient outcome and lowers patient mortality rate, therefore regarded as preferred treatment option for the heart strokes. Acute ischemic stroke is more severe and common form of all the strokes, particularly among old age people and occurs frequently in women as compared to men. According to the market estimates of the UK Stroke Association, in UK, each year more than 100,000 strokes were reported, and around 1 in 10 people having hemorrhage, die prematurely.

行业动态

Growth Drivers
中风或心脏病发作是全球最常见的伤员形式，倾向于采用有关产品。根据世卫组织的估计，2016年，由于中风，发生了大约1510万人死亡。此外，根据疾病和对照中心的说法，在美国的疾病和87％的中风中是缺血性的。这有望推动神经脱髓形术装置的市场增长。

On the same ground, to further substantiate arguments, Southwestern Medical Center published that each year around 795,000 people suffer from a stroke. Thus, the rising prevalence of ischemic heart diseases is anticipated to drive the adoption of such neurothrombectomy devices.

Moreover, several government initiatives to spread awareness and prevention of heart strokes. For instance, the WISEWOMAN program was started by the U.S.-based CDC in states to minimize the risks of stroke and to promote healthy lifestyles. Such programs were targeted at un-insured women in low-income group populations. Thus, such initiatives are expected to provide awareness about the ill effects of stroke in the market.

神经脱层术署市场报告范围

The market is primarily segmented on the basis of product, end-use, and region.

由产品	通过最终使用	按地区
凝块钉子抽吸/抽吸装置 Vascular Snares	医院紧急诊所外科手术中心	北美（美国，加拿大）欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷）中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

产品洞察力

基于该产品，全球神经脱髓球菌装置的市场被分叉进入凝块检索器，抽吸/抽吸装置和血管圈。2020年，CLOT牵引赛段占收入份额最大。它主要用于从脑动脉中去除血液凝块。神经脱髓球菌器件行业的产品部门的高度归因于缺血性心脏病和新产品发布的普遍存在。此外，血液相关遗传性疾病的上升案例也有利于细胞间切除术装置的生长。

然而，由于其在外科医生的偏好，期望吸气装置段预计将在预计期间注册最高的增长率。神经脱髓球菌装置的兴起，增加老年人口，也补充了细分市场的增长。此外，这种装置从血管中真空凝血凝血，并高精度地重新血管化大闭塞。

最终用途的洞察

Based on the end-use, the global market for neurothrombectomy devices is bifurcated into hospitals, emergency clinics, and ambulatory surgical centers. In 2020, the hospital market segment accounted for the largest revenue share of global market for neurothrombectomy devices. This is because, hospitals are preferred over other healthcare facilities, by patients, owing to the presence of advanced medical facilities and skilled surgeons. Moreover, hospitals have partnerships with insurance companies, which makes it easier for the patients to access their medical insurance.

但是，预计ASCS市场部门将在预计期间注册利润丰厚的增长率。患者对ASCS的偏好归因于其低治疗循环时间，因为大量的外患者手术是以ASCS进行的。这种低位等待时间和患者结果，青睐龙眼切除术装置的市场段的生长。

地理概述

Geographically, the global market for neurothrombectomy devices is bifurcated into North America, Asia Pacific, Europe, Latin America, and MEA. North America is the largest revenue contributor followed by Europe and the Asia Pacific region. In 2020, the European region accounted for over 32 percent of the global neurothrombectomy devices market.

负责此类市场增长的区域因素包括该地区的缺血性心脏中风的风险，出血性上升，消费者对微创手术的偏好以及对研发的资金上升。根据EM咨询的估计，大约110万人患有中风，再加上创新产品的产品推出。